{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T20:31:33Z","timestamp":1790022693481,"version":"4.0.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T00:00:00Z","timestamp":1598400000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T00:00:00Z","timestamp":1598400000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009459","name":"Hvidovre Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009459","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>People who inject drugs (PWID) have increased risk of acquiring blood-transmitted chronic viral infections such as Hepatitis B (HBV), Hepatitis C (HCV) and Human Immunodeficiency Virus (HIV) as well as increased risk of acquiring bacterial infections. We aimed to identify and describe bacteraemic episodes, their recurrence rates, predictive and prognostic factors amongst hospitalised PWID.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>In this retrospective cohort study, we included 257 hospitalised PWID during 2000\u20132006 with follow up at the Department of Infectious Diseases, Hvidovre Hospital, Denmark. Data collection included comorbidity (HBV-, HCV-, HIV-, and psychiatric comorbidities), social information (contact to an addiction treatment centre, homelessness), opioid substitution treatment (OST), treatment completion and microbiology findings. There was a 10-years follow-up regarding mortality.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>The study identified 257 patients classified as PWID. Of these, 58 (22.6%) had at least one episode of bacteraemia during their first hospital admission. Recurrence was found in 29 (50.0%) of the bacteraemia cases. <jats:italic>Staphylococcus aureus<\/jats:italic> was the dominant microorganism of both first and recurrent episodes with 24 (41.4%) and nine (31.4%) of cases, respectively. A psychiatric diagnose was significantly associated with a lower risk of bacteraemia in the multivariate analysis (OR: 0.29, [95%CI: 0.11\u20130.77], <jats:italic>P<\/jats:italic>\u00a0=\u20090.01). Mortality was significantly higher in patients with bacteraemia (17.2% vs. 3.0%, <jats:italic>P<\/jats:italic>\u00a0&lt;\u20090.01, OR: 6.67 [95%CI: 2.33\u201320], <jats:italic>P<\/jats:italic>\u00a0&lt;\u20090.01).<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>In hospitalised PWID, bacteraemia was found in 22.6% and was associated with at higher mortality. The most common microorganism of bacteraemia was <jats:italic>S. aureus<\/jats:italic>. Psychiatric comorbidity was significantly associated with a lower risk of bacteraemia.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12879-020-05357-0","type":"journal-article","created":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T04:12:03Z","timestamp":1598415123000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Prevalence and recurrence of bacteraemia in hospitalised people who inject drugs \u2013 a single Centre retrospective cohort study in Denmark"],"prefix":"10.1186","volume":"20","author":[{"given":"Sara","family":"Th\u00f8nnings","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0670-9996","authenticated-orcid":false,"given":"Filip","family":"Jans\u00e5ker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoffer","family":"Sundqvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebekka Faber","family":"Thudium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne Dam","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny Dahl","family":"Knudsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,26]]},"reference":[{"key":"5357_CR1","unstructured":"Narkotikasituationen I Danmark 2017. Available at: www.sst.dk. (Accessed: 6th September 2019)."},{"key":"5357_CR2","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1093\/clinids\/11.3.486","volume":"11","author":"C Scheidegger","year":"1989","unstructured":"Scheidegger C, Zimmerli W. Infectious complications in drug addicts: seven-year review of 269 hospitalized narcotics abusers in Switzerland. Rev Infect Dis. 1989;11:486\u201393.","journal-title":"Rev Infect Dis"},{"key":"5357_CR3","first-page":"511","volume":"13","author":"TW Lavender","year":"2013","unstructured":"Lavender TW, McCarron B. Acute infections in intravenous drug users. Clin Med J Royal Coll Phys London. 2013;13:511\u20133.","journal-title":"Clin Med J Royal Coll Phys London"},{"key":"5357_CR4","first-page":"415","volume":"165","author":"A Palepu","year":"2001","unstructured":"Palepu A, et al. Hospital utilization and costs in a cohort of injection drug users. C Can Med Assoc J. 2001;165:415.","journal-title":"C Can Med Assoc J"},{"key":"5357_CR5","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1093\/aje\/kwu032","volume":"179","author":"K Koch","year":"2014","unstructured":"Koch K, et al. Socioeconomic inequalities in risk of hospitalization for community-acquired bacteremia: a Danish population-based case-control study. Am J Epidemiol. 2014;179:1096\u2013106.","journal-title":"Am J Epidemiol"},{"key":"5357_CR6","first-page":"252","volume":"69","author":"T Aagaard","year":"2014","unstructured":"Aagaard T, et al. Long-term mortality after Staphylococcus aureus spondylodiscitis: a Danish nationwide population-based cohort study. J Inf Secur. 2014;69:252\u20138.","journal-title":"J Inf Secur"},{"key":"5357_CR7","first-page":"191","volume":"60","author":"US Jensen","year":"2010","unstructured":"Jensen US, et al. Recurrent bacteraemia: a 10-year regional population-based study of clinical and microbiological risk factors. J Inf Secur. 2010;60:191\u20139.","journal-title":"J Inf Secur"},{"key":"5357_CR8","doi-asserted-by":"publisher","first-page":"e1192","DOI":"10.1016\/S2214-109X(17)30375-3","volume":"5","author":"L Degenhardt","year":"2017","unstructured":"Degenhardt L, et al. Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review. Lancet Glob Heal. 2017;5:e1192\u2013207.","journal-title":"Lancet Glob Heal"},{"key":"5357_CR9","doi-asserted-by":"publisher","first-page":"449","DOI":"10.2147\/CLEP.S91125","volume":"7","author":"M Schmidt","year":"2015","unstructured":"Schmidt M, et al. The Danish National Patient Registry: a review of content, data quality, and research potential. Clin Epidemiol. 2015;7:449\u201390.","journal-title":"Clin Epidemiol"},{"key":"5357_CR10","unstructured":"Murray, P. R. & American Society for Microbiology. Manual of clinical microbiology. (ASM Press, 1999)."},{"key":"5357_CR11","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1056\/NEJMoa022139","volume":"348","author":"GS Martin","year":"2003","unstructured":"Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 2003;348:1546\u201354.","journal-title":"N Engl J Med"},{"key":"5357_CR12","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1111\/1469-0691.12195","volume":"19","author":"M Goto","year":"2013","unstructured":"Goto M, Al-Hasan MN. Overall burden of bloodstream infection and nosocomial bloodstream infection in North America and Europe. Clin Microbiol Infect. 2013;19:501\u20139.","journal-title":"Clin Microbiol Infect"},{"key":"5357_CR13","doi-asserted-by":"publisher","first-page":"2440","DOI":"10.1017\/S0950268816000613","volume":"144","author":"KB Laupland","year":"2016","unstructured":"Laupland KB, Pasquill K, Parfitt EC, Naidu P, Steele L. Burden of community-onset bloodstream infections, Western interior, British Columbia, Canada. Epidemiol Infect. 2016;144:2440\u20136.","journal-title":"Epidemiol Infect"},{"key":"5357_CR14","first-page":"111","volume":"70","author":"SL Nielsen","year":"2015","unstructured":"Nielsen SL, et al. Bacteremia is associated with excess long-term mortality: a 12-year population-based cohort study. J Inf Secur. 2015;70:111\u201326.","journal-title":"J Inf Secur"},{"key":"5357_CR15","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1001\/archinte.1994.00420040071011","volume":"154","author":"JA Capdevila","year":"1994","unstructured":"Capdevila JA, et al. Incidence and risk factors of recurrent episodes of bacteremia in adults. Arch Intern Med. 1994;154:411\u20135.","journal-title":"Arch Intern Med"},{"key":"5357_CR16","first-page":"199","volume":"67","author":"L Wiese","year":"2013","unstructured":"Wiese L, et al. A nationwide study of comorbidity and risk of reinfection after Staphylococcus aureus bacteraemia. J Inf Secur. 2013;67:199\u2013205.","journal-title":"J Inf Secur"},{"key":"5357_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7326\/0003-4819-67-1-1","volume":"67","author":"DB Louria","year":"1967","unstructured":"Louria DB, Hensle T, Rose J. The major medical complications of heroin addiction. Ann Intern Med. 1967;67:1\u201322.","journal-title":"Ann Intern Med"},{"key":"5357_CR18","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.7326\/0003-4819-119-10-199311150-00009","volume":"119","author":"CE Cherubin","year":"1993","unstructured":"Cherubin CE, Sapira JD. The medical complications of drug addiction and the medical assessment of the intravenous drug user: 25 years later. Ann Intern Med. 1993;119:1017\u201328.","journal-title":"Ann Intern Med"},{"key":"5357_CR19","doi-asserted-by":"publisher","first-page":"S279","DOI":"10.1093\/clinids\/20.Supplement_2.S279","volume":"20","author":"PH Summanen","year":"1995","unstructured":"Summanen PH, et al. Bacteriology of skin and soft-tissue infections: comparison of infections in intravenous drug users and individuals with no history of intravenous drug use. Clin Infect Dis. 1995;20:S279\u201382.","journal-title":"Clin Infect Dis"},{"key":"5357_CR20","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/0895-4356(96)00180-1","volume":"49","author":"IJB Spijkerman","year":"1996","unstructured":"Spijkerman IJB, Van Ameijden EJC, Mientjes GHC, Coutinho RA, Van Den Hoek A. Human immunodeficiency virus infection and other risk factors for skin abscesses and endocarditis among injection drug users. J Clin Epidemiol. 1996;49:1149\u201354.","journal-title":"J Clin Epidemiol"},{"key":"5357_CR21","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1093\/clinids\/8.3.374","volume":"8","author":"DP Levine","year":"1986","unstructured":"Levine DP, Crane LR, Zervos MJ. Bacteremia in narcotic addicts at the Detroit medical center. II infectious endecarditis: A prospective comparative study. Rev Infect Dis. 1986;8:374\u201396.","journal-title":"Rev Infect Dis"},{"key":"5357_CR22","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1093\/clinids\/8.3.364","volume":"8","author":"LR Crane","year":"1986","unstructured":"Crane LR, Levine DP, Zervos MJ, Cummings G. Bacteremia in narcotic addicts at the detroit medical center. I. Microbiology, epidemiology, risk factors, and empiric therapy. Rev Infect Dis. 1986;8:364\u201373.","journal-title":"Rev Infect Dis"},{"key":"5357_CR23","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s15010-004-3106-0","volume":"32","author":"S Bassetti","year":"2004","unstructured":"Bassetti S, Battegay M. Staphylococcus aureus infections in injection drug users: risk factors and prevention stategies. Infection. 2004;32:163\u20139.","journal-title":"Infection"},{"key":"5357_CR24","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1111\/j.1469-0691.2010.03262.x","volume":"17","author":"J Wilson","year":"2011","unstructured":"Wilson J, et al. Trends among pathogens reported as causing bacteraemia in England, 2004-2008. Clin Microbiol Infect. 2011;17:451\u20138.","journal-title":"Clin Microbiol Infect"},{"key":"5357_CR25","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1111\/j.1469-0691.2008.02089.x","volume":"14","author":"KB Laupland","year":"2008","unstructured":"Laupland KB, Gregson DB, Church DL, Ross T, Pitout JDD. Incidence, risk factors and outcomes of Escherichia coli bloodstream infections in a large Canadian region. Clin Microbiol Infect. 2008;14:1041\u20137.","journal-title":"Clin Microbiol Infect"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05357-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-020-05357-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05357-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,25]],"date-time":"2021-08-25T23:13:07Z","timestamp":1629933187000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-020-05357-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,26]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["5357"],"URL":"https:\/\/doi.org\/10.1186\/s12879-020-05357-0","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,26]]},"assertion":[{"value":"11 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Danish committee on biomedical research ethics for the capitol region of Denmark approved the study (7\u2013505\u201329-369\/1). Registry-based research does not require informed consent in Denmark.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors have completed the ICMJE uniform disclosure form (available on request from the corresponding author) and declare: no support from any organisation for the submitted work; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years, no other relationships or activities that could appear to have influenced the submitted work.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"634"}}